Skip to main content
. 2018 Oct 11;24:7264–7270. doi: 10.12659/MSM.908678

Figure 2.

Figure 2

Comparisons of indicators after IVIG or combination of IVIG and infliximab treatments. (A) Therapeutic effect indicator: duration of fever, length of hospital stay, and occurrence rate of refractory KD. (B) Complications indictors: coronary artery (CA) dilation and CA aneurysms. (C) Economic indicator: hospitalization expenses.